Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease treated by nonsteroidal anti-inflammatory drugs (NSAIDs) including lornoxicam (LX). Nanocarriers have been used to increase the efficacy and reduce the side effects of various drugs. The objective of the present study was to com...

Descripción completa

Detalles Bibliográficos
Autores principales: Helmy, Hebatullah Samy, El-Sahar, Ayman E, Sayed, Rabab H, Shamma, Rehab Nabil, Salama, Alaa Hamed, Elbaz, Eman Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626385/
https://www.ncbi.nlm.nih.gov/pubmed/29026298
http://dx.doi.org/10.2147/IJN.S147738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626385/
https://www.ncbi.nlm.nih.gov/pubmed/29026298
http://dx.doi.org/10.2147/IJN.S147738

Ejemplares similares